Aandeel MIDATECH PHARMA PLC
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Midatech Pharma PLC Nasdaq

Aandelen

US59564R1041

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading
Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading
Sector Update: Health Care Stocks Edge Higher Late Afternoon
Sector Update: Health Care Stocks Higher in Afternoon Trading
European Equities Close Higher in Friday Trading; Anglo American Rejects BHP Takeover Bid
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers BDRX
  4. Koers
  5. Nieuws Midatech Pharma PLC
  6. Andere talen